|
DPH3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.441800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.538800E-01 |
| Normal-vs-Stage2 |
5.260800E-01 |
| Normal-vs-Stage3 |
3.881800E-01 |
| Normal-vs-Stage4 |
2.504400E-01 |
| Stage1-vs-Stage2 |
7.957200E-01 |
| Stage1-vs-Stage3 |
6.303600E-01 |
| Stage1-vs-Stage4 |
2.755200E-01 |
| Stage2-vs-Stage3 |
8.959400E-01 |
| Stage2-vs-Stage4 |
4.676200E-01 |
| Stage3-vs-Stage4 |
5.260800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.586100E-02 |
| Normal-vs-AfricanAmerican |
3.630200E-01 |
| Normal-vs-Asian |
3.930600E-01 |
| Caucasian-vs-AfricanAmerican |
7.563400E-01 |
| Caucasian-vs-Asian |
3.635600E-01 |
| AfricanAmerican-vs-Asian |
4.989000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.118190E-01 |
| Normal-vs-Female |
7.496000E-02 |
| Male-vs-Female |
4.893400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.266600E-01 |
| Normal-vs-Extreme_Weight |
9.447200E-01 |
| Normal-vs-Obese |
5.849900E-02 |
| Normal-vs-Extreme_Obese |
7.445600E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.853800E-01 |
| Normal_Weight-vs-Obese |
2.847200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.752800E-01 |
| Extreme_Weight-vs-Obese |
6.388100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.679400E-01 |
| Obese-vs-Extreme_Obese |
5.611600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.377400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.341800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.285800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.277040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.268600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.005800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.762200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.338300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.615200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.161600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.349600E-02 |
| Normal-VS-Type2 PRCC |
6.967800E-01 |
| Normal-VS-KIRP CIMP |
1.437650E-01 |
| Normal-VS-Unclassified PRCC |
2.541900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.272300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.964200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.422580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.125600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.121750E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.414800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.968600E-01 |
| Normal-vs-N1 |
5.498200E-02 |
| Normal-vs-N2 |
7.474400E-01 |
| N0-vs-N1 |
4.989700E-02 |
| N0-vs-N2 |
6.368600E-01 |
| N1-vs-N2 |
5.509400E-01 |
|
|
